-
digital.ahrq.gov/ahrq-funded-projects/testing-clinical-decision-support-treating-tobacco-use-dental-clinics/annual-summary/2011
January 01, 2011 - Testing Clinical Decision Support for Treating Tobacco Use in Dental Clinics - 2011
Project Name
Testing Clinical Decision Support for Treating Tobacco Use in Dental Clinics
Principal Investigator
Shelley, Donna
Organization
New York University School of Medicine
Fund…
-
digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/lead-high-risk-area-and-age-4-years-due
December 08, 2000 - Lead, (High risk area AND Age= 4 years), Due for Screening
Clinician Summary
American Academy of Pediatrics Policy Statement:
Because recent epidemiologic data have shown that lead exposure is still common in certain communities in theUnited States, the Centers for Disease Control and Prevention recently …
-
digital.ahrq.gov/2019-year-review/research-spotlights/improving-care-advancing-evidence-practice-through-interoperable
January 01, 2019 - Improving Care: Advancing Evidence into Practice through Interoperable, Patient-Centered Clinical Decision Support
The uptake of research evidence in clinical practice can be slow. Technologies such as CDS can accelerate the uptake by putting the latest evidence-based recommendations at…
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/kuperman-gj-et-al-2003
January 01, 2003 - Kuperman GJ et al. 2003 "Computer physician order entry: benefits, costs, and issues."
Reference
Kuperman GJ, Gibson RF. Computer physician order entry: benefits, costs, and issues. Ann Intern Med 2003;139(1):31-39.
Abstract
"Several analyses have detected substantial quality problems througho…
-
digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-age-9m-12m.pdf
December 08, 2000 - Pediatric Rules and Reminders - Lead, (Age= 9-12 months), Due for Screening
Pediatric Rules and Reminders
Lead, (Age= 9-12 months), Due for Screening
Clinician Summary
American Academy of Pediatrics Policy Statement:
Because recent epidemiologic data have shown that lead exposure is still common…
-
digital.ahrq.gov/sites/default/files/docs/page/lead-elevated-retesting-due.pdf
December 08, 2000 - Pediatric Rules and Reminders - Elevated Lead, Due for retesting
Pediatric Rules and Reminders
Elevated Lead, Due for retesting
Clinician Summary
American Academy of Pediatrics Policy Statement:
Because recent epidemiologic data have shown that lead exposure is still common
in certain communiti…
-
digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-high-risk-age-4y.pdf
December 08, 2000 - Pediatric Rules and Reminders - Lead, (High risk area AND Age= 4 years), Due for Screening
Pediatric Rules and Reminders
Lead, (High risk area AND Age= 4 years), Due for Screening
Clinician Summary
American Academy of Pediatrics Policy Statement:
Because recent epidemiologic data have shown th…
-
digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-age-2y.pdf
December 08, 2000 - Pediatric Rules and Reminders - Lead, (Age= 2 years), Due for Screening
Pediatric Rules and Reminders
Lead, (Age= 2 years), Due for Screening
Clinician Summary
American Academy of Pediatrics Policy Statement:
Because recent epidemiologic data have shown that lead exposure is still common
in cer…
-
digital.ahrq.gov/sites/default/files/docs/page/lead-screening-due-age-3y.pdf
December 08, 2000 - Pediatric Rules and Reminders - Lead, (Age = 3 years), Due for Screening
Pediatric Rules and Reminders
Lead, (Age = 3 years), Due for Screening
Clinician Summary
American Academy of Pediatrics Policy Statement:
Because recent epidemiologic data have shown that lead exposure is still common
in c…
-
digital.ahrq.gov/sites/default/files/docs/nlp-slides-041112.pdf
April 11, 2012 - generalized this approach and are
applying it to assessing obesity treatment (as
prescribed by the NHLBI guideline
-
digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/informatics-systems-promote
Informatics systems to promote improved care for chronic illness: a literature review
Authors: Dorr, D., Bonner, L. M., Cohen, A. N., Shoai, R. S., Perrin, R., Chaney, E., Young, A. S. Journal: J Am Med Inform Assoc Publication Date: 2007 Mar-Apr Volume: 14 Issue: 2 Pages: 156-63 HIT Description: Var…
-
digital.ahrq.gov/sites/default/files/docs/implementation/Lobach.ppt
August 12, 2005 - Structuring Clinical Practice Guidelines in a Relational Database Model for Decision Support on the Internet
©2005 David F. Lobach
Showing
Health Information Value in a Community Network
David F. Lobach, MD, PhD, MS
Division of Clinical Informatics
Department of Community and Family Medicine
Duke University Me…
-
digital.ahrq.gov/health-it-tools-and-resources/evaluation-resources/workflow-assessment-health-it-toolkit/all-workflow-tools/pert-chart
January 01, 2023 - Program Evaluation and Review Technique Chart
Acronym
PERT
Also Known As
PERT Chart
Description
Program evaluation and review technique (PERT) charts are useful when managing a project. It is used to streamline project planning and scheduling. The method is particularly useful when…
-
digital.ahrq.gov/health-it-tools-and-resources/pediatric-resources/pediatric-rules-and-reminders/%20chlamydia-ocp-medication-list-and-last-screen-12-months-due-chlamydia-screen
January 01, 2003 - Chlamydia, (OCP on medication list AND Last screen >12 months), Due for Chlamydia screen
Clinician Summary
The US Preventive Services Task Force strongly recommends that clinicians routinely screen all sexually active women aged 25 years and younger, and other asymptomatic women at increased risk for infe…
-
digital.ahrq.gov/sites/default/files/docs/survey/national-electronic-health-records-survey-2012.pdf
January 01, 2012 - Providing reminders for guideline-based
interventions or screening tests?
18g.
-
digital.ahrq.gov/sites/default/files/docs/activity/2011_021002_shelley_pdf_3.pdf
January 01, 2011 - Testing Clinical Decision Support for Treating Tobacco Use in Dental Clinics
1 | TesTing CliniCal DeCision supporT for TreaTing TobaCCo use in
DenTal CliniCs
Exploratory and dEvElopmEntal Grant to ImprovE HEaltH CarE QualIty
tHrouGH HEaltH InformatIon tECHnoloGy (It) (r21)
Testing Clinical Decision Support for T…
-
digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/preventing-provider-errors
April 01, 2004 - Preventing provider errors: online total parenteral nutrition calculator
Authors: Lehmann, C. U., Conner, K. G., Cox, J. M. Journal: Pediatrics Publication Date: 2004 Apr Volume: 113 Issue: 4 Pages: 748-53 HIT Description: decision support Ð clinical guidelines, CPOE More info... Purpose of Study: …
-
digital.ahrq.gov/principal-investigator/fricton-james
January 01, 2023 - Fricton, James
Decision Support to Improve Dental Care for Medically Compromised Patients - Final Report
Citation
Fricton, J. Decision Support to Improve Dental Care for Medically Compromised Patients - Final Report. (Prepared by HealthPartners Research Foundation under Grant …
-
digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/toth-pal-e
January 01, 2023 - Toth-Pal E et al. 2008 "Implementing a clinical decision-support system in practice: a qualitative analysis of influencing attitudes and characteristics among general practitioners."
Reference
Toth-Pal E, Wardh I, Strender L-E, et al. Implementing a clinical decision-support system in practice: a qual…
-
digital.ahrq.gov/sites/default/files/docs/citation/k08hs018582-lafleur-final-report-2015.pdf
January 01, 2015 - screening, and treatment rates are driven by differences in guidelines,
such as different methods for guideline … screening alone to identify 55% of women and 80% of men who have fragility
fractures.9 The NOF’s treatment guideline … either sex, has been found to have acceptable
discrimination in men, but is not incorporated into the guideline … osteoporotic patients (adapted from Britain’s National Institute for Health and
Care Excellence (NICE) guideline … risk would receive bisphosphonate treatment even without bone densitometry (suggested by the
NICE guideline